REYVOW: payments to doctors
Payments that named REYVOW as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.3M
- Providers
- 40,774
- Transactions
- 147,903
- Average per transaction
- $43
The per-transaction average — $43 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 40,774 providers the average total is $155, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $5,944,097 | 94.3% |
| Pfizer | $356,461 | 5.7% |
| Eli Lilly Export S.A. Puerto Rico Branch | $2,924 | 0.0% |
| Eli Lilly | $1,160 | 0.0% |